Pharmacological manipulation of peroxisome proliferator-activated receptor γ (PPARγ) reveals a role for anti-oxidant protection in a model of Parkinson's disease

by Martin, Heather L., Mounsey, Ross B., Mustafa, Sarah, Sathe, Kinnari, Teismann, Peter
Published 2012

Evidence for a role of adaptive immune response in the disease pathogenesis of the MPTP mouse model of Parkinson's disease

by Martin, Heather L., Santoro, Matteo, Mustafa, Sarah, Riedel, Gernot, Forrester, John V., Teismann, Peter
Published 2015

Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

by Mounsey, Ross B., Mustafa, Sarah, Robinson, Lianne, Ross, Ruth A., Riedel, Gernot, Pertwee, Roger G., Teismann, Peter
Published 2015

S100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway

by Sathe, Kinnari, Maetzler, Walter, Lang, Johannes D., Mounsey, Ross B., Fleckenstein, Corina, Martin, Heather L., Schulte, Claudia, Mustafa, Sarah, Synofzik, Matthis, Vukovic, Zvonimir, Itohara, Shigeyoshi, Berg, Daniela, Teismann, Peter
Published 2012